Director of R&D

Global Oligonucleotide Synthesis Market to Cross USD 7 Billion by 2032 | DelveInsight

Chris Rombach appointed President of Asahi Kasei Bioprocess America

Asahi Kasei Bioprocess America and GeminiBio Enter Strategic Partnership to Advance Application of Inline Buffer Formulation and Streamline Biopharmaceutical Manufacturing Processes

Associate Director, Patient Access Operations

Veloxis Pharmaceuticals is an Asahi-Kasei Group Company dedicated to transforming transplant medicine. The Associate Director, Patient Access Operations is responsible for supporting the Field Access and Patient Support Program teams through data analytics, project management, and operational excellence, while ensuring compliance with healthcare laws and regulations.

Sign up with Google

Sign in with Google